NEW YORK, July 11, 2022 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Syros Pharmaceuticals, Inc. SYRS
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Syros Pharmaceuticals, Inc. SYRS in connection with the proposed merger of SYRS with TYME Technologies, Inc. ("TYME"). Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME's expected net cash at closing, and TYME stockholders are expected to receive approximately 0.4312 shares of Syros common stock for each share of TYME common stock. If you own SYRS shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/syrs
Convey Health Solutions Holdings, Inc. CNVY
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Convey Health Solutions Holdings, Inc. CNVY, in connection with the proposed acquisition of CNVY by TPG Capital. Pursuant to the merger agreement, CNVY shareholders will receive $10.50 in cash for each share of CNVY common stock. If you own CNVY shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/cnvy
RADA Electronic Industries Ltd. RADA
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of RADA Electronic Industries Ltd. RADA, in connection with the proposed merger of RADA with Leonardo DRS Inc. ("Leonardo DRS"). Upon completion of the transaction, Leonardo DRS will acquire 100% of the share capital in RADA in exchange for approximately 19.5% equity ownership to RADA shareholders in the combined company. If you own RADA shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/rada
Silicon Motion Technology Corporation SIMO
Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Silicon Motion Technology Corporation SIMO, in connection with the proposed acquisition of SIMO by MaxLinear, Inc. ("MaxLinear "). Pursuant to the merger agreement, the transaction consideration will consist of $93.54 in cash and 0.388 shares of MaxLinear stock for each Silicon Motion ADS (American Depositary Share), and $23.385 in cash and 0.097 shares of MaxLinear common stock for each SIMO ordinary share not represented by an ADS. If you own SIMO shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/simo
SOURCE Weiss Law
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.